ZURAZura Bio Limited
$4.12+3.3% 1Y
$4.12
$3.2152 weeks$7.04
ZURA as reported
- Net income
- −$86M
Net income · +27% year on year · trailing twelve months to Q2 2026
- Free cash flow
- −$38M
Free cash flow · −13% year on year · trailing twelve months to Q2 2026
- EPS
- −$1.13
EPS · +61% year on year · trailing twelve months to Q2 2026
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Net income | −$86M | +27% | Q2 2026 |
| EPS | −$1.13 | +61% | Q2 2026 |
| ROE | −52% | n/a | Q2 2026 |
| ROA | −45% | n/a | Q2 2026 |
| Free cash flow | −$38M | −13% | Q2 2026 |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
Zura Bio Limited (ZURA) · Net incomeNet incomeZura Bio Limited (ZURA)